JP Patent

JP6543268B2 — 嚢胞性線維症膜コンダクタンス調節因子が媒介する疾患を処置するための医薬組成物

Assigned to Vertex Pharmaceuticals Inc · Expires 2019-07-10 · 7y expired

What this patent protects

Patent listed against Kalydeco.

Drugs covered by this patent

Patent Metadata

Patent number
JP6543268B2
Jurisdiction
JP
Classification
—
Expires
2019-07-10
Drug substance claim
No
Drug product claim
No
Assignee
Vertex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.